Of violent clashes with protesters breaking barricades and Fire Crackers going off. Where do things go from here . Plus, Columbia University asking police to stay on campus for weeks after a chaotic night where officers went into a building where protesters were barricaded. The school now going remote for the rest of the semester. And donald trump taking advantage of a day off from court. The former president plans miz his First Campaign rally since his criminal trial began. Were live in battleground, wisconsin. And a new decision from the Federal Reserve on Interest Rates. What it means for your bottom line and the never ending battle against inflation. Our nbc News Reporters are following all of the latest developments. We begin with nbcs Steve Patterson who is at ucla where police are standing by. Steve, whats the latest there . Chris, the latest is happening behind me right now. Its the most action we have seen all day. Im going to step off and show it to you. Take a look. You can
correspondent david spunt is in wilmington, delaware tonight awaiting a verdict. david, good evening. david: trace, good evening. jurors will be back tomorrow for day two of deliberations. they deliberated about an hour today before going home. over the past week we saw salacious text messages, pictures in the courtroom. even high profile people sitting in the audience. but, in the end, it s all about this one gun form, hunter biden filled out in october 2018. hunter biden s attorney abbe lowell offered no reason for his client deciding not to testify in his own defense .38 caliber revolver. such a move would have been strategically risky. opening the president s son to likely intense cross-examination. in closing arguments. prosecutor pointed to more than a dozen msnbc of the biden family in the audience saying they don t matter. only the evidence does. which he called, quote: ugly and overwhelming. another prosecutor added no one is above the law. including the presiden
Reclassifying marijuana from its status as a Schedule 1 narcotic to a lower-risk category could be a great boon for the market but it might negatively impact patients.